Clinical Trials
Source: CCM
- Score: 5Children's Health, Headaches
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)
- Ages6 years - 17 years
- GenderBoth
- Score: 4Child Development & Autism, Brain, Spinal Cord & Nervous System, Genetics, Mental Health & Behavioral Research
Genetic and molecular studies of developmental neuropsychiatric disorders
- GenderBoth
- Score: 3Children's Health, Genetics
Pediatric Genomics Discovery Program (PGDP)
- GenderBoth
- Score: 2Child Development & Autism, Mental Health & Behavioral Research
123-MOMS: Pregnant women in their second trimester who plan on delivering at Yale New Haven Hospital UPDATE
- Score: 1Brain, Spinal Cord & Nervous System, Mental Health & Behavioral Research
Teen Brain and Behavior Study
- Ages13 years - 17 years
- GenderBoth
- Score: 0Headaches
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)
- Ages6 years - 17 years
- GenderBoth